Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

1.

The role of dopamine in motivation for food in humans: implications for obesity.

Wang GJ, Volkow ND, Fowler JS.

Expert Opin Ther Targets. 2002 Oct;6(5):601-9. Review.

PMID:
12387683
[PubMed - indexed for MEDLINE]
2.

Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine.

Salamone JD, Correa M.

Behav Brain Res. 2002 Dec 2;137(1-2):3-25. Review.

PMID:
12445713
[PubMed - indexed for MEDLINE]
3.

Dopamine/adenosine interactions involved in effort-related aspects of food motivation.

Salamone JD, Correa M.

Appetite. 2009 Dec;53(3):422-5. doi: 10.1016/j.appet.2009.07.018. Epub 2009 Jul 25. Review.

PMID:
19635514
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review.

Wang GJ, Volkow ND, Thanos PK, Fowler JS.

J Addict Dis. 2004;23(3):39-53. Review.

PMID:
15256343
[PubMed - indexed for MEDLINE]
5.

Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications.

Hoebel BG, Hernandez L, Schwartz DH, Mark GP, Hunter GA.

Ann N Y Acad Sci. 1989;575:171-91; discussion 192-3. Review.

PMID:
2699187
[PubMed - indexed for MEDLINE]
6.

Relationships between mesolimbic dopamine function and eating behavior.

Smith GP, Schneider LH.

Ann N Y Acad Sci. 1988;537:254-61. Review.

PMID:
3059927
[PubMed - indexed for MEDLINE]
7.

Dopamine-related frontostriatal abnormalities in obesity and binge-eating disorder: emerging evidence for developmental psychopathology.

Michaelides M, Thanos PK, Volkow ND, Wang GJ.

Int Rev Psychiatry. 2012 Jun;24(3):211-8. doi: 10.3109/09540261.2012.679918. Review.

PMID:
22724642
[PubMed - indexed for MEDLINE]
8.

Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

Blum K, Chen TJ, Downs BW, Bowirrat A, Waite RL, Braverman ER, Madigan M, Oscar-Berman M, DiNubile N, Stice E, Giordano J, Morse S, Gold M.

Postgrad Med. 2009 Nov;121(6):176-96. doi: 10.3810/pgm.2009.11.2087. Review.

PMID:
19940429
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Central dopaminergic circuitry controlling food intake and reward: implications for the regulation of obesity.

Vucetic Z, Reyes TM.

Wiley Interdiscip Rev Syst Biol Med. 2010 Sep-Oct;2(5):577-93. doi: 10.1002/wsbm.77. Review.

PMID:
20836049
[PubMed - indexed for MEDLINE]
10.

Striatocortical pathway dysfunction in addiction and obesity: differences and similarities.

Tomasi D, Volkow ND.

Crit Rev Biochem Mol Biol. 2013 Jan-Feb;48(1):1-19. doi: 10.3109/10409238.2012.735642. Epub 2012 Nov 23. Review.

PMID:
23173916
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The biology of motivation.

Grossman SP.

Annu Rev Psychol. 1979;30:209-42. Review. No abstract available.

PMID:
375810
[PubMed - indexed for MEDLINE]
12.

[Functional role and pharmacological regulation of the dopaminergic system of the brain].

RaevskiÄ­ KS.

Vestn Ross Akad Med Nauk. 1998;(8):19-24. Review. Russian.

PMID:
9771125
[PubMed - indexed for MEDLINE]
13.

Genetic variation in dopaminergic reward in humans.

Stice E, Dagher A.

Forum Nutr. 2010;63:176-85. doi: 10.1159/000264405. Epub 2009 Nov 27. Review.

PMID:
19955785
[PubMed - indexed for MEDLINE]
14.

Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary.

Blum K, Chen AL, Chen TJ, Braverman ER, Reinking J, Blum SH, Cassel K, Downs BW, Waite RL, Williams L, Prihoda TJ, Kerner MM, Palomo T, Comings DE, Tung H, Rhoades P, Oscar-Berman M.

Theor Biol Med Model. 2008 Nov 12;5:24. doi: 10.1186/1742-4682-5-24. Review.

PMID:
19014506
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.

Heidbreder CA, Gardner EL, Xi ZX, Thanos PK, Mugnaini M, Hagan JJ, Ashby CR Jr.

Brain Res Brain Res Rev. 2005 Jul;49(1):77-105. Review.

PMID:
15960988
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Ghrelin and food reward: the story of potential underlying substrates.

Skibicka KP, Dickson SL.

Peptides. 2011 Nov;32(11):2265-73. doi: 10.1016/j.peptides.2011.05.016. Epub 2011 May 19. Review.

PMID:
21621573
[PubMed - indexed for MEDLINE]
17.

Hedonic and incentive signals for body weight control.

Egecioglu E, Skibicka KP, Hansson C, Alvarez-Crespo M, Friberg PA, Jerlhag E, Engel JA, Dickson SL.

Rev Endocr Metab Disord. 2011 Sep;12(3):141-51. doi: 10.1007/s11154-011-9166-4. Review.

PMID:
21340584
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Reward deficiency syndrome: genetic aspects of behavioral disorders.

Comings DE, Blum K.

Prog Brain Res. 2000;126:325-41. Review.

PMID:
11105655
[PubMed - indexed for MEDLINE]
19.

Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.

Salamone JD, Correa M, Farrar A, Mingote SM.

Psychopharmacology (Berl). 2007 Apr;191(3):461-82. Epub 2007 Jan 16. Review.

PMID:
17225164
[PubMed - indexed for MEDLINE]
20.

Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action.

Jentsch JD, Roth RH, Taylor JR.

Prog Brain Res. 2000;126:433-53. Review.

PMID:
11105661
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk